title: [Medical care of the cancer patient - Is it really so different?].
abstract: Cancer deaths contribute to more than 25% of the overall mortality in Germany, which is only superseded by death from cardiovascular diseases. Apart from improving cancer prevention, the development of effective therapies for advanced cancer is a key task in oncology. Here we compare the criteria of clinical effectiveness that are applied to medical cancer therapies with those that are applied to therapies for cardiovascular diseases. (As supplied by publisher).
authors.affiliation: Westdeutsches Tumorzentrum, Innere Klinik (Tumorforschung), Universitätsklinikum Essen, Essen. Martin.Schuler@uk-essen.de
authors.forename: Martin
authors.initials: M
authors.lastname: Schuler
mesh_terms: D002423:Cause of Death; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003430:Cross-Sectional Studies; D023381:Endpoint Determination; D005858:Germany; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000517:prevention & control / Q000628:therapy*; D009203:Myocardial Infarction / Q000401:mortality / Q000517:prevention & control / Q000628:therapy; D016032:Randomized Controlled Trials as Topic; D015607:Stents; D016019:Survival Analysis; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D010959:Tissue Plasminogen Activator